US 11420931
Lipid containing formulations
granted A61KA61K31/325A61K47/34
Quick answer
US patent 11420931 (Lipid containing formulations) held by ARBUTUS BIOPHARMA CORPORATION expires Mon Aug 18 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- ARBUTUS BIOPHARMA CORPORATION
- Grant date
- Tue Aug 23 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 18 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K31/325, A61K47/34, A61K9/1272, A61K9/1273